OxC-beta approval in the United States has opened business opportunities for the Canadian-based company
Canadian biotech and animal health company Avivagen has received more than $5 million in funding intended to increase its presence in the U.S. marketplace. The company, based in Ottawa, Ontario, makes natural health products intended to replace antibiotics added to livestock feeds to promote productivity, particularly weight gain and feed conversion efficiency. “Avivagen...
To see the full article, please Register